| Primary |
| Hiv Infection |
69.2% |
| Tuberculosis |
15.4% |
| Suicide Attempt |
3.8% |
| Castleman's Disease |
2.9% |
| Diabetes Mellitus |
2.9% |
| Salvage Therapy |
2.9% |
| Antifungal Prophylaxis |
1.9% |
| Anaemia Prophylaxis |
1.0% |
|
| Immune Reconstitution Syndrome |
11.5% |
| Virologic Failure |
11.5% |
| Pregnancy |
7.7% |
| Rhabdomyolysis |
7.7% |
| Accidental Poisoning |
3.8% |
| Blood Creatinine Increased |
3.8% |
| Cardiopulmonary Failure |
3.8% |
| Convulsion |
3.8% |
| Deep Vein Thrombosis |
3.8% |
| Dehydration |
3.8% |
| Depression |
3.8% |
| Dermatitis Bullous |
3.8% |
| Hepatotoxicity |
3.8% |
| Incorrect Dose Administered |
3.8% |
| Low Birth Weight Baby |
3.8% |
| Maternal Exposure During Pregnancy |
3.8% |
| Multiple Drug Overdose |
3.8% |
| Muscular Weakness |
3.8% |
| Myositis |
3.8% |
| Neuropathy Peripheral |
3.8% |
|
| Secondary |
| Hiv Infection |
59.0% |
| Drug Exposure During Pregnancy |
8.3% |
| Drug Use For Unknown Indication |
7.8% |
| Product Used For Unknown Indication |
7.6% |
| Antiretroviral Therapy |
6.2% |
| Antiviral Treatment |
1.6% |
| Hypertension |
1.4% |
| Tuberculosis |
1.2% |
| Prophylaxis |
0.8% |
| Hepatitis C |
0.8% |
| Prophylaxis Against Transplant Rejection |
0.8% |
| Pneumocystis Jiroveci Pneumonia |
0.7% |
| Hiv Test Positive |
0.7% |
| Gestational Diabetes |
0.6% |
| Antifungal Prophylaxis |
0.5% |
| Acquired Immunodeficiency Syndrome |
0.5% |
| Depression |
0.4% |
| Intervertebral Disc Protrusion |
0.4% |
| Plasma Cell Myeloma |
0.4% |
| Cough |
0.4% |
|
| Weight Decreased |
11.4% |
| Renal Failure Acute |
9.0% |
| Progressive External Ophthalmoplegia |
8.7% |
| Umbilical Cord Abnormality |
7.3% |
| Gastrointestinal Malformation |
6.0% |
| Liver Function Test Abnormal |
6.0% |
| Thrombocytopenia |
5.4% |
| Ventricular Hypertrophy |
5.2% |
| Respiratory Failure |
4.3% |
| Drug Exposure During Pregnancy |
4.1% |
| Premature Labour |
3.5% |
| Viral Load Increased |
3.5% |
| Weight Increased |
3.5% |
| Hepatic Failure |
3.3% |
| Hypersensitivity |
3.3% |
| Immune Reconstitution Syndrome |
3.3% |
| Premature Baby |
3.3% |
| Abortion Spontaneous |
3.0% |
| Death |
3.0% |
| Premature Rupture Of Membranes |
3.0% |
|
| Concomitant |
| Hiv Infection |
60.3% |
| Product Used For Unknown Indication |
14.6% |
| Drug Use For Unknown Indication |
4.8% |
| Hepatitis C |
3.3% |
| Antiretroviral Therapy |
3.0% |
| Prophylaxis |
2.1% |
| Hypertension |
1.5% |
| Vitamin Supplementation |
1.4% |
| B-cell Lymphoma |
1.1% |
| Tuberculosis |
0.9% |
| Acquired Immunodeficiency Syndrome |
0.8% |
| Mineral Supplementation |
0.8% |
| Drug Exposure During Pregnancy |
0.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.7% |
| Depression |
0.7% |
| Pain |
0.7% |
| Diarrhoea |
0.7% |
| Premedication |
0.7% |
| Antifungal Prophylaxis |
0.6% |
| Gastric Ulcer |
0.6% |
|
| Vomiting |
14.3% |
| Myocardial Infarction |
9.1% |
| Rash |
8.7% |
| Pneumonia |
5.2% |
| Sepsis |
5.2% |
| Weight Decreased |
5.2% |
| Renal Failure |
4.8% |
| Rhabdomyolysis |
4.8% |
| Pyrexia |
4.3% |
| Abortion Spontaneous |
3.9% |
| Renal Failure Acute |
3.9% |
| Cerebrovascular Accident |
3.5% |
| Colon Cancer |
3.5% |
| Drug Interaction |
3.5% |
| Dyspnoea |
3.5% |
| Off Label Use |
3.5% |
| Septic Shock |
3.5% |
| Thrombocytopenia |
3.5% |
| Urosepsis |
3.5% |
| Hodgkin's Disease |
3.0% |
|
| Interacting |
| Hiv Infection |
27.6% |
| Product Used For Unknown Indication |
23.5% |
| Drug Use For Unknown Indication |
18.8% |
| Antiretroviral Therapy |
14.1% |
| Bipolar Disorder |
3.5% |
| Antiviral Treatment |
2.9% |
| Psychotic Disorder |
2.9% |
| Opportunistic Infection Prophylaxis |
1.8% |
| Bronchopulmonary Aspergillosis |
1.2% |
| Drug Withdrawal Maintenance Therapy |
1.2% |
| Deep Vein Thrombosis |
0.6% |
| Pruritus Generalised |
0.6% |
| Pyrexia |
0.6% |
| Rash |
0.6% |
|
| Drug Interaction |
41.2% |
| White Blood Cell Count Increased |
17.6% |
| Hepatic Failure |
11.8% |
| Urine Amphetamine Positive |
11.8% |
| Ventricular Tachycardia |
11.8% |
| Psychotic Disorder |
5.9% |
|
